Molecure S.A. (WSE: MOC)
Health Care · Pharmaceuticals · PL
zł6.14
-0.49% today · -21.1% 1Y
Molecure S.A. (WSE: MOC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $34.42M and employs 102 people.
Over the last twelve months the share price has lost 21.1%, trading between 4.98 and 9.04.
Tweenvest scores Molecure S.A. across four factors: quality 36/100, value 45/100, growth 100/100. Its strongest factor is growth.
MOC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.42M
- Revenue (TTM)
- $1.81M
- P/E
- —
- EPS
- -0.76
- Dividend yield
- —
- Beta (5Y)
- 1.00
- 52-week high
- zł9.04
- 52-week low
- zł4.98
- Avg volume (3M)
- —
- Shares outstanding
- 20.60M
- Employees
- 102
- Next earnings
- —
About Molecure S.A.
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
- ISIN
- PLONCTH00011
- Founded
- 2012
- Listed since
- Apr 19, 2018
- Exchange
- Warsaw Stock Exchange
- Currency
- PLN
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.44 | -0.28% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.51 | -0.93% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.36 | -0.20% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.30 | +0.24% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £122.24 | +0.94% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.92 | -0.18% |
Figures last refreshed Aug 18, 2026.